Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinomaSunisa Prasopporn, Siwanon Jirawatnotai|Frontiers in Oncology|2022Cited by 12
Establishment of novel cholangiocarcinoma cell lines with ARID1A deficiency and preclinical validation of synthetic lethality therapiesSunisa Prasopporn, Siwanon Jirawatnotai|Scientific Reports|2025Cited by 1